Paul Hennessy | LightRocket | Getty Images
Federal prosecutors have charged 14 people — together with a medical physician and homeowners of laboratories, pharmacies and a house well being company — in a number of Covid-related fraud schemes that allegedly bilked customers and insurers out of $143 million, the Department of Justice announced Wednesday.
In addition, the Center for Program Integrity on the Centers for Medicare & Medicaid Services introduced it took administrative motion towards greater than 50 medical suppliers for his or her involvement in health-care fraud schemes regarding Covid-19.
The DOJ’s Fraud Section, which leads the Medicare Fraud Strike Force, introduced it’s prosecuting circumstances in the next districts: Western District of Arkansas, Northern District of California, Middle District of Louisiana, Central District of California, Southern District of Florida, District of New Jersey and the Eastern District of New York.
“These medical professionals, company executives, and others allegedly took benefit of the COVID-19 pandemic to line their very own pockets as a substitute of offering wanted well being care companies throughout this unprecedented time in our nation,” Deputy Attorney General Lisa Monaco stated. “We are decided to carry those that exploit such applications accountable to the fullest extent of the legislation.”
FBI Director Christopher Wray additionally stated the company is dedicated to combating Covid-related health-care fraud. “Medical suppliers have been the unsung heroes. … It’s disheartening that some have abused their authorities.”
The defendants allegedly engaged in numerous forms of schemes “designed to take advantage of the COVID-19 pandemic,” the DOJ stated in a information launch.
“For instance, a number of defendants provided COVID-19 assessments to Medicare beneficiaries at senior residing amenities, drive-through COVID-19 testing websites, and medical workplaces to induce the beneficiaries to offer their private figuring out data and a saliva or blood pattern,” the DOJ stated. “The defendants are alleged to have then misused the knowledge and samples to submit claims to Medicare for unrelated, medically pointless, and much costlier laboratory assessments, together with most cancers genetic testing, allergy testing, and respiratory pathogen panel assessments.” The DOJ stated the proceeds of the schemes have been allegedly laundered via shell firms and used to purchase unique vehicles and luxurious actual property.
In one other instance, a defendant allegedly exploited telehealth regulation expansions to submit fraudulent claims to Medicare for telemedicine encounters that by no means occurred, in line with the DOJ. Telehealth laws had been broadened after Covid-19 was acknowledged as a nationwide emergency to offer Medicare beneficiaries larger entry to a wider vary of companies so they might keep away from dangerous journey to health-care websites.
Here are a few of the circumstances the DOJ introduced it’s prosecuting:
In Arkansas, a person who owns two testing laboratories was charged with health-care fraud in reference to an alleged scheme to defraud the U.S. of greater than $88 million. The man allegedly used entry to beneficiary and medical supplier data from prior lab testing orders to submit tons of of fraudulent claims for urine, drug and different assessments. Some of the falsely submitted claims have been for beneficiaries who have been already lifeless.
A health care provider in New Jersey allegedly ordered costly and medically pointless most cancers genetic testing for Medicare beneficiaries that attended a Covid-19 testing occasion that he participated in. The man additionally allegedly billed Medicare for companies to beneficiaries that he by no means offered, totaling about $19 million in health-care fraud schemes.
Another man in the state who was a companion at a diagnostic testing lab allegedly provided kickbacks in trade for respiratory pathogen assessments that have been improperly bundled with Covid assessments and billed to Medicare. The man allegedly paid and acquired bribes in a scheme totaling $5.four million.
In New York, charges have been introduced towards two people who owned a number of pharmacies and sham pharmacy wholesaling firms for allegedly committing health-care fraud, wire fraud and cash laundering totaling $45 million. The two and their co-conspirators allegedly acquired billing privileges for a number of pharmacies. They additionally allegedly submitted fraudulent claims to Medicare by abusing emergency Covid-19 guidelines to keep away from in any other case relevant limits on refills for costly medication. The DOJ information launch stated the defendants “allegedly used an elaborate community of worldwide cash laundering operations to hide and disguise the proceeds of the scheme.”